Skip to main content
Toggle navigation
Login
Search
Home
Scientific Program
Back
View
Attendees
3
Favorite
Like
Facebook
Tweet
Print
Session: Novel Pathways and Approaches in Allergic Disease
Computational Engineering of Major Allergens to Reduce Allergenicity and Maintain Immunogenicity Enables Safe and Effective Immunotherapy for Food Allergy
Wednesday, June 19, 2024
8:30 AM – 9:00 AM
PT
Location: Salon 8
Speaker(s)
Yanay Ofran, PhD
Founder
Ukko, Inc., Israel
Disclosure(s):
Yanay Ofran, PhD
: No relevant disclosure to display
Learning Objectives:
1. Upon completion, participant will be able to define the role of allergen immunogenicity in immunotherapy.
2. Upon completion, participant will be able to define the biological underpinnings for success or failure of existing treatments for food allergy.
3. Upon completion, participant will be able to understand ways in which AI may enhance development of new therapies.